Top 15 Leading Players in India Melanoma Market | Competitive Landscape 2026

India Melanoma Market Overview

According to 6Wresearch, the India melanoma market is undergoing a steady expansion driven by rising diagnostic awareness and the increasing availability of global standard cancer therapies. While melanoma remains less common in India compared to Western nations, the rising incidence among urban populations and the diagnostic challenges of acral lentiginous melanoma (the most common subtype in India) have spurred a demand for specialized care. Furthermore, the use of dermoscopy along with AI based digital skin screening in specialized clinics has strengthened the market.

Competitive Landscape

The competitive landscape of the India melanoma market is characterized by a balanced presence of government funded research institutions, high-capacity private hospital networks, and prominent global pharmaceutical companies. Collaborations between Indian diagnostic chains and multinational biotechnology companies have reinforced the market, positioning India as a leading destination for cost-effective, evidence-based melanoma treatment.

Below is a list of leading players operating in the India Melanoma Market:

1. Tata Memorial Hospital

India's premier cancer research and treatment center, providing subsidized and highly specialized surgical and medical oncology services for melanoma patients nationwide.

2. Apollo Cancer Centres

A leading private healthcare provider utilizing advanced proton therapy and robotic surgery for precise management of metastatic melanoma across multiple Indian cities.

3. Bristol Myers Squibb

A global biopharmaceutical leader that pioneered dual immunotherapy (Nivolumab and Ipilimumab) for metastatic melanoma, significantly impacting survival rates in the Indian market.

4. Roche

Specializes in targeted therapies and diagnostic assays, focusing on -mutated melanoma treatments and innovative fixed-dose subcutaneous oncology formulations.

5. All India Institute of Medical Sciences (AIIMS)

The country's leading public medical university, featuring a dedicated Cancer Center that leads research into the unique genetic profiles of Indian melanoma patients.

6. HCG Cancer Centre

One of the largest providers of cancer care in India, offering specialized precision oncology and genomic profiling to customize treatment plans for rare skin cancer subtypes.

7. Max Institute of Cancer Care

Renowned for its multidisciplinary approach and high-end diagnostic technology, including PET-CT imaging and immunohistochemistry for accurate staging.

8. Fortis Memorial Research Institute

A quaternary care hospital known for its expertise in complex skin cancer surgeries and advanced chemotherapy and immunotherapy protocols.

9. Natco Pharma

A key domestic pharmaceutical player that manufactures high-quality, affordable generic oncology drugs, improving the accessibility of melanoma treatments in India.

10. Core Diagnostics

A high-end diagnostic laboratory specializing in advanced molecular testing and oncopathology, providing critical genetic data for targeted melanoma therapy.

11. Kidwai Memorial Institute of Oncology

A prominent regional cancer center providing affordable comprehensive oncology care and a robust public health focus on skin cancer screening.

12. Cipla

A major pharmaceutical giant providing a wide range of supportive care medications and generic therapies essential for comprehensive melanoma management.

13. Medanta – The Medicity

A leading multi-specialty facility that integrates dermatological surgery and medical oncology to offer seamless care for primary and recurrent melanoma cases.

14. Rajiv Gandhi Cancer Institute

A dedicated oncology hospital featuring a specialized tumor board and advanced pathology services focused on the early detection of melanocytic lesions.

15. AstraZeneca

A leading global biopharmaceutical company introducing cutting-edge targeted drugs and collaborating on large-scale clinical trials for immunotherapy in India.